$COGT Cogent Biosciences, Inc. Insider Trading
Get free email notifications about insider trading in Cogent Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cogent Biosciences, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cogent Biosciences, Inc. for free.
CIK Number: 0001622229
IRS Number: 465308248
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: COGT
Company Address: 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE 02140
Phone number: 617-945-5576
Former name: Unum Therapeutics, Inc., date of change: 2014-10-14
Cogent Biosciences, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | COGT | Cogent Biosciences ... | Kearns Evan | Chief Legal Officer | Option Exercise | A | 8.93 | 260,000 | 2,321,800 | 260,000 | |
Apr 28 2021 | COGT | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Sell | S | 8.86 | 17,813 | 157,823 | 3,841 | 21.7 K to 3.8 K (-82.26 %) |
Apr 05 2021 | COGT | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 9.08 | 2,121 | 19,259 | 2,121 | |
Apr 05 2021 | COGT | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 9.08 | 2,068 | 18,777 | 2,068 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Harwin Peter Evan | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Shegog Todd | Director | Option Exercise | A | 8.45 | 22,500 | 190,125 | 22,500 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Ros Matthew | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | CAIN CHRISTOPHER W. | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Mar 15 2021 | UMRX | Cogent Biosciences ... | Morris Arlene | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
Mar 01 2021 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Grant | A | 0.00 | 524 | 0 | 21,654 | 21.1 K to 21.7 K (+2.48 %) |
Feb 24 2021 | UMRX | Cogent Biosciences ... | Shegog Todd | Director | Option Exercise | A | 8.59 | 37,500 | 322,125 | 37,500 | |
Feb 12 2021 | UMRX | Cogent Biosciences ... | Robbins Andrew R | President and CEO | Option Exercise | A | 10.17 | 315,200 | 3,205,584 | 315,200 | |
Feb 12 2021 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Option Exercise | A | 10.17 | 270,746 | 2,753,487 | 270,746 | |
Feb 12 2021 | UMRX | Cogent Biosciences ... | Green John L. | Chief Financial Off ... | Option Exercise | A | 10.17 | 111,300 | 1,131,921 | 111,300 |